Amphastar Pharmaceuticals, Inc. (AMPH) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Amphastar Pharmaceuticals, Inc. (AMPH) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

AMPH

Market Closed

Amphastar Pharmaceuticals, Inc.

NASDAQHealthcare Drug Manufacturers - Specialty & Generic

1.98K employees

CEO: Yongfeng Zhang

Founded: 2014

$20.22

+$0.00(+NaN%)

Market Cap

891.56M

Beta

0.89

52W Range

N/A

Dividend Yield

1.48%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

49.5%

-4.8%

CAGR: 15.5%

Profit after direct costs

Operating Margin

19.5%

-31.7%

CAGR: 19.1%

Core business profitability

Net Margin

13.6%

-38.5%

CAGR: 12.1%

Bottom line profitability

Revenue Growth

-1.7%

YoY

CAGR: 13.2%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how AMPH allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

49.5%

$356.06M

Operating Margin

19.5%

$140.40M

Net Margin

13.6%

$98.09M

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	437.77M	498.99M	644.39M	731.97M	719.89M	-1.7%
Cost of Revenue	(238.03M)	(250.13M)	(293.27M)	(358.11M)	(363.83M)	1.6%
Gross Profit	199.74M	248.86M	351.12M	373.86M	356.06M	-4.8%
Operating Expenses
Research & Development	(60.93M)	(74.77M)	(73.74M)	(73.91M)	(85.84M)	16.1%
Selling, General & Administrative	(68.92M)	(66.59M)	(80.39M)	(94.52M)	(129.81M)	37.3%
General & Administrative	(51.43M)	(45.06M)	(51.54M)	(56.72M)	(85.92M)	51.5%
Selling & Marketing	(17.49M)	(21.53M)	(28.85M)	(37.80M)	(43.88M)	16.1%
Depreciation & Amortization	(26.53M)	(28.27M)	(41.78M)	(57.20M)	(63.20M)	10.5%
Operating Income (EBIT)	69.89M	107.50M	196.99M	205.42M	140.40M	-31.7%
Non-Operating Items
Interest Income	601.00K	1.32M	5.46M	10.61M	8.68M	-18.2%
Interest Expense	(885.00K)	(1.85M)	(27.16M)	(30.34M)	(25.48M)	-16.0%
Other Income/Expenses (Net)	14.04M	7.37M	-27.61M	-16.23M	-16.78M	3.4%
Income Before Tax	83.93M	114.86M	169.38M	189.19M	123.62M	-34.7%
Income Tax Expense	(20.63M)	(23.48M)	(31.83M)	(29.67M)	(25.53M)	-14.0%
Net Income	62.12M	91.39M	137.54M	159.52M	98.09M	-38.5%
Per Share Metrics
Earnings Per Share (Basic)	$1	$2	$3	$3	$2	-36.2%
Weighted Avg Shares Outstanding	47.78M	48.55M	48.27M	48.43M	46.74M	-3.5%
Weighted Avg Shares Outstanding (Diluted)	49.78M	52.43M	53.00M	52.06M	48.22M	-7.4%
EBITDA	111.56M	146.16M	240.29M	277.31M	212.31M	-23.4%

Explore AMPH

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

AMPH in the Healthcare

Small Cap

Healthcare

Browse sector stocks →

Drug Manufacturers - Specialty & Generic

Browse industry stocks →